Insulet | PODD - 贸易债权人



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 480.4M
销售成本
USD 232.7M
流动资产
USD 1.71B
流动负债
USD 687.5M
债务
USD 949.2M
EBIT
USD 122M
EBITDA
USD 181.7M
员工
3.9K
EPS每股收益
USD 1.42
股本和储备
USD 1.3B
销售毛利
USD 540.8M
债务利息支出
USD 14.7M
利息收入
USD 5.7M
贷款资金
USD 929.5M
市值
USD 10.19B
净收入
USD 91.1M
营业费用
USD 639.7M
营业利润
USD 122M
普通股股本
USD 69.26M
PE价格收益
38.83
税前利润
USD 113M
销售收入
USD 761.7M
销售和管理费用
USD 317.2M
股票
USD 462.5M
贸易债权人
USD 149.8M
应收帐款人
USD 544.7M


贸易债权人 更改 日
Abbott USD 4.24B 117M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
AtriCure USD 70.06M 8.34M 2026-03
Avanos Medical USD 52.3M 3.2M 2026-03
Baxter International USD 1.09B 87M 2026-03
Becton, Dickinson and Co. USD 5.93B 204M 2026-03
Boston Scientific USD 1.14B 3M 2026-03
Cardinal Health USD 37.83B 1.16B 2026-03
Cooper Companies USD 225.8M 74.6M 2025-12
Dexcom USD 1.94B 109.1M 2026-03
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Globus Medical USD 103.66M 4.81M 2026-03
ICU Medical USD 173.98M 19.61M 2026-03
Inogen USD 21.22M 684K 2025-09
Insulet USD 149.8M 74.8M 2026-03
Integra LifeSciences USD 87.95M 7.78M 2026-03
J&J USD 10.46B 1.53B 2026-03
Masimo USD 89M 14M 2026-03
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 67.85M 7.3M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Solventum Corp USD 699M 12M 2026-03
Stryker USD 1.8B 301M 2025-12
Tandem Diabetes Care USD 59.86M 12.79M 2026-03
Teleflex USD 143.63M 13.43M 2026-03
West Pharmaceutical Services USD 252.3M 1.4M 2026-03
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03